A detailed history of Janus Henderson Group PLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 545,173 shares of HALO stock, worth $25.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
545,173
Previous 513,302 6.21%
Holding current value
$25.7 Million
Previous $26.9 Million 16.05%
% of portfolio
0.02%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$51.3 - $64.42 $1.63 Million - $2.05 Million
31,871 Added 6.21%
545,173 $31.2 Million
Q2 2024

Aug 14, 2024

SELL
$37.81 - $52.4 $673,887 - $933,925
-17,823 Reduced 3.36%
513,302 $26.9 Million
Q1 2024

May 15, 2024

BUY
$33.68 - $41.95 $3.47 Million - $4.32 Million
102,911 Added 24.03%
531,125 $21.6 Million
Q4 2023

Feb 14, 2024

BUY
$33.32 - $42.1 $42,449 - $53,635
1,274 Added 0.3%
428,214 $15.8 Million
Q3 2023

Nov 14, 2023

SELL
$36.46 - $44.03 $37,590 - $45,394
-1,031 Reduced 0.24%
426,940 $16.3 Million
Q2 2023

Aug 14, 2023

SELL
$30.28 - $38.74 $2,816 - $3,602
-93 Reduced 0.02%
427,971 $15.4 Million
Q1 2023

May 15, 2023

SELL
$32.86 - $55.7 $7.1 Million - $12 Million
-216,078 Reduced 33.55%
428,064 $16.3 Million
Q4 2022

Feb 14, 2023

SELL
$40.06 - $59.44 $1.82 Million - $2.7 Million
-45,394 Reduced 6.58%
644,142 $36.7 Million
Q3 2022

Nov 14, 2022

BUY
$38.53 - $51.78 $57,640 - $77,462
1,496 Added 0.22%
689,536 $27.3 Million
Q2 2022

Aug 15, 2022

SELL
$37.35 - $48.3 $1.56 Million - $2.02 Million
-41,735 Reduced 5.72%
688,040 $30.3 Million
Q1 2022

May 16, 2022

BUY
$31.97 - $41.06 $1.86 Million - $2.39 Million
58,204 Added 8.67%
729,775 $29.1 Million
Q4 2021

Feb 14, 2022

BUY
$31.82 - $40.75 $419,260 - $536,922
13,176 Added 2.0%
671,571 $27 Million
Q3 2021

Nov 16, 2021

BUY
$38.47 - $46.42 $251,555 - $303,540
6,539 Added 1.0%
658,395 $26.8 Million
Q2 2021

Aug 16, 2021

SELL
$38.84 - $51.31 $1.22 Million - $1.61 Million
-31,313 Reduced 4.58%
651,856 $29.6 Million
Q1 2021

May 17, 2021

SELL
$39.51 - $51.45 $4.59 Million - $5.98 Million
-116,241 Reduced 14.54%
683,169 $28.5 Million
Q4 2020

Feb 16, 2021

SELL
$25.81 - $43.62 $2.32 Million - $3.92 Million
-89,893 Reduced 10.11%
799,410 $34.1 Million
Q3 2020

Nov 16, 2020

BUY
$25.74 - $29.63 $22.9 Million - $26.4 Million
889,303 New
889,303 $23.4 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.57B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.